Predicting treatment outcomes using >18>F|FDG PET biomarkers in ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

PET/CT variables and NLR were useful biomarkers for predicting outcomes of patients with NSCLC receiving pembrolizumab and chemotherapy as a ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

Among various PD-1 inhibitors, pembrolizumab and nivolumab have been shown to significantly prolong the survival in patients with advanced NSCLC. ... Importantly, ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

We retrospectively enrolled 52 patients with advanced NSCLC who underwent baseline 18F-FDG PET/CT before treatment initiation. PET/CT parameters ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

has become the mainstay treatment strategy for. Predicting treatment outcomes using. 18F-FDG PET biomarkers in patients with non-small-cell lung cancer.

Predicting treatment outcomes using >18>F-FDG PET biomarkers in ...

Background: Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) ...

Predicting treatment outcomes using 18 F-FDG PET biomarkers in ...

Conclusion PET/CT variables and NLR were useful biomarkers for predicting outcomes of patients with NSCLC receiving pembrolizumab and ...

Prediction of Treatment Outcome and Survival Using 18F-FDG PET ...

Conclusions: Radiomic features extracted from baseline FDG PET/CT images were mostly unsuccessful at predicting OS, PFS, or DICB treatment ...

FDG PET biomarkers for prediction of survival in metastatic ... - Nature

Fifty-six patients, without prior systemic treatment, BRAF wild type, explored using 18F-FDG PET were included retrospectively. Our primary ...

Utility of 18F-FDG uptake in predicting major pathological response ...

A comprehensive comparative analysis between the predicting utility of 18F-FDG PET-CT and other tools was conducted. Our results showed that 18F-FDG uptake had ...

Use of 18F-FDG PET/CT as a Predictive Biomarker of Outcome in ...

FDG PET has been shown to be useful in the diagnosis and management of head-and-neck cancer [13–18]. The intensity of FDG uptake is emerging as a valuable ...

Prognostic value of 18F-FDG PET/CT in patients with ... - Frontiers

Compared to baseline 18F-FDG PET/CT imaging, the pooled hazard ratios (HR) of maximum and mean standardized uptake values SUVmax, SUVmean, MTV ...

18F-FDG PET as a Candidate for “Qualified Biomarker”

Why now? Formal recognition by the NCI of the potential importance of 18F-FDG PET in monitoring treatment response has been motivated by the search for ...

Pretreatment 18-FDG-PET/CT parameters can serve as prognostic ...

Original Article. Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation- ...

18F-FDG PET can effectively rule out conversion to dementia and ...

A normal brain 18 F-FDG PET scan can help rule out the risk of dementia conversion and the presence of cerebrospinal fluid (CSF) biomarker of neurodegeneration ...

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for ...

Background: [18F]FDG PET/CT is used for staging and could also provide information associated with clinical outcomes. The objective of this ...

18F-FDG uptake in PET/CT is a potential predictive biomarker of ...

In this study, we evaluated the relationship between 18F-FDG uptake on PET/CT and the response to anti-PD-1 therapy in patients with advanced or ...

Predictive value of integrated 18F-FDG PET/MRI in the early ...

F-FDG PET/MRI and CT were performed within 2 weeks before (baseline) and between 11 and 14 days (2 weeks) after initiation of nivolumab therapy. When disease ...

The role of 18F−FDG PET in predicting the pathological ... - Frontiers

Conclusion: 18F-FDG PET is a valuable tool for predicting pathological response and prognosis of unresectable HCC patients treated by Lenvatinib ...

Early prediction of treatment outcome for lenvatinib using 18 F-FDG ...

We attempted to confirm that FDG PET/CT can predict treatment outcome 1 week after the initiation of lenvatinib treatment and to our knowledge, ...

Imaging Biomarkers to Predict Outcomes in Patients With Large B ...

Day 28 partial response by PET/CT following chimeric antigen receptor T-cell therapy creates clinical uncertainty for both clinicians and ...